Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 1, 2011, Pages 64-70

  Yang, Ju Dong ^a   Kim, W Ray ^a   Coelho, Ritika ^a   Mettler, Teresa A ^a   Benson, Joanne T ^b   Sanderson, Schuyler O ^b   Therneau, Terry M ^b   Kim, Bohyun ^b   Roberts, Lewis R ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

Liver Cancer; Liver Disease; Survival; Virology

Indexed keywords

ADULT; ARTICLE; ASCITES; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; SPLENOMEGALY; THROMBOCYTOPENIA; VIRUS REPLICATION;

AGED; ASCITES; CARCINOMA, HEPATOCELLULAR; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FIBROSIS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PREVALENCE; SPLENOMEGALY; THROMBOCYTOPENIA;

EID: 78650253568     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.08.019     Document Type: Article

References (31)

1. Yang J.D., Roberts L.R. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010, 7:448-458.
2. Perz J.F., Armstrong G.L., Farrington L.A., et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45:529-538.
3. Colombo M., de Franchis R., Del Ninno E., et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991, 325:675-680.
4. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
5. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma-the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 2000, 31:840-845. The Cancer of the Liver Italian Program (CLIP) Investigators.
6. Llovet J.M., Bru C., Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 19:329-338.
7. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985, 56:918-928.
8. Budhu A., Wang X.W. The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 2006, 80:1197-1213.
9. Bonilla Guerrero R., Roberts L.R. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J Hepatol 2005, 42:760-777.
10. Paterlini-Brechot P., Saigo K., Murakami Y., et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 2003, 22:3911-3916.
11. Branda M., Wands J.R. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology 2006, 43:891-902.
12. Yen T.S. Hepadnaviral X protein: review of recent progress. J Biomed Sci 1996, 3:20-30.
13. Bralet M.P., Regimbeau J.M., Pineau P., et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000, 32:200-204.
14. De Mitri M.S., Poussin K., Baccarini P., et al. HCV-associated liver cancer without cirrhosis. Lancet 1995, 345:413-415.
15. Tabibian J.H., Landaverde C., Winn J., et al. Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis. Ann Hepatol 2009, 8:64-67.
16. Shiratori Y., Shiina S., Imamura M., et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995, 22:1027-1033.
17. Takano S., Yokosuka O., Imazeki F., et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995, 21:650-655.
18. Chen C.J., Yang H.I., Su J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006, 295:65-73.
19. Lin S.M., Sheen I.S., Chien R.N., et al. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999, 29:971-975.
20. Matsumoto A., Tanaka E., Rokuhara A., et al. Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: a multicenter retrospective study of 2795 patients. Hepatol Res 2005, 32:173-184.
21. van Zonneveld M., Honkoop P., Hansen B.E., et al. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology 2004, 39:804-810.
22. Yuen M.F., Seto W.K., Chow D.H., et al. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease. Antivir Ther 2007, 12:1295-1303.
23. Chen J.D., Yang H.I., Iloeje U.H., et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 2010, 138:1747-1754.
24. Xu J., Shi J., Wang Y.P., et al. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis. Med Sci Monit 2009, 15:CR274-CR279.
25. Yuen M.F., Yuan H.J., WongDK, et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 2005, 54:1610-1614.
26. Camma C., Giunta M., Andreone P., et al. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 2001, 34:593-602.
27. Nishiguchi S., Shiomi S., Nakatani S., et al. Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet 2001, 357:196-197.
28. Valla D.C., Chevallier M., Marcellin P., et al. Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment. Hepatology 1999, 29:1870-1875.
29. Pawlik T.M., Poon R.T., Abdalla E.K., et al. Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. J Gastrointest Surg 2004, 8:794-804.
30. Chen M.F., Jeng L.B., Lee W.C. Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World J Surg 2002, 26:742-747.
31. Miyagawa S., Kawasaki S., Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996, 24:307-310.